IP Verse

Stolmr & Partner patent opposition analysis

The comprehensive analysis of Stolmr & Partner opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Stolmr & Partner

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP4212152	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Jan 30, 2026	EGIS GYGYSZERGYR ZRTKREN MKD RSZVNYTRSASG
EP4321157	New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)	NOVARTIS	Jul 18, 2025	EGIS GYGYSZERGYR ZRTKREN MKD RSZVNYTRSASG
EP3626270	New Use	NOVARTIS	Jul 8, 2024	EGIS GYGYSZERGYR ZRTKREN MKD RSZVNYTRSASG
EP3294283	Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure	NOVARTIS	Oct 9, 2023	EGIS GYGYSZERGYR ZRTKREN MKD RSZVNYTRSASG
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	Jul 11, 2023	EGIS GYGYSZERGYR ZRTKREN MKD RSZVNYTRSASG
EP2234617	Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters	JANSSEN PHARMACEUTICA	Dec 31, 2021	EGIS GYGYSZERGYR ZRTKREN MKD RSZVNYTRSASG
EP2617807	Culture Substrate	ASAHI GLASS	Jul 21, 2021	STOLMR & PARTNER
EP3307798	Alignment Compounds	TRANSITIONS OPTICAL	May 4, 2021	STOLMR & PARTNER
EP3207132	Methods Of Shifting An Isoelectric Profile Of A Protein Product And Uses Thereof	ALEXION PHARMACEUTICALS	Apr 30, 2020	STOLMR
EP2933321	Grease Composition Ameliorating Low-Temperature Fretting	KYODO YUSHI	Nov 13, 2019	KLBER LUBRICATION MNCHEN

Top companies who are the clients of Stolmr & Partner

Company	Total
EGIS GYGYSZERGYR ZRTKREN MKD RSZVNYTRSASG	7
STOLMR	2
STOLMR & PARTNER	2
KLBER LUBRICATION MNCHEN	1